Market Place
Sourcing Support
Iksuda To Unveil Oesophageal Cancer Data From IKS014 Phase 1
06 Jan 2026 //
BUSINESSWIRE
Iksuda Presents Encouraging IKS014 Phase 1 Data At ESMO
21 Oct 2025 //
PHARMIWEB
Iksuda To Present IKS014 Phase 1 Data At ESMO
14 Oct 2025 //
PHARMIWEB
Iksuda Therapeutics Receives FDA IND Clearance for IKS014
30 Jun 2025 //
BUSINESSWIRE
Iksuda Therapeutics doses first patient in IKS03 Trial
30 May 2025 //
BUSINESSWIRE
Iksuda to Present Growing ADC Pipeline at AACR
25 Apr 2025 //
BUSINESSWIRE
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014
23 Oct 2023 //
BUSINESSWIRE
Iksuda Deepens Clinical Pipeline Through Licensing Agreement From LegoChem
10 Jan 2022 //
BUSINESSWIRE
LegoChem Bio signs $1B deal with UK biotech
27 Dec 2021 //
KOREABIOMED
SOTIO expands its ADC pipeline via agreement with LegoChem
17 Nov 2021 //
THEPHARMALETTER
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.